Table of Content


1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Central Nervous System Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Central Nervous System Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Central Nervous System Drugs Market Regional Analysis
9.1. Global Central Nervous System Drugs Market, 2019, By Region, Value ($ Billion)
9.2. Global Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

10. Central Nervous System Drugs Market Segmentation
10.1. Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Analgesics
Anti-Parkinson drugs
Anesthetics
Anti-Epileptics
Other CNS drugs
10.2. Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Hospital Pharmacies
Retail Pharmacies/ Drug Stores
Others
10.3. Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Oral
Parenteral
Others
10.4. Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Branded Drugs
Generic Drugs
10.5. Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Prescription-Based Drugs
Over-The-Counter Drugs

11. Central Nervous System Drugs Market Metrics
11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2015-2023, Global
11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Central Nervous System Drugs Market
12.1. Asia-Pacific Central Nervous System Drugs Market Overview
12.2. Asia-Pacific, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
12.3. Asia-Pacific, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
12.4. Asia-Pacific, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics
12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Asia-Pacific Countries
12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Asia-Pacific Countries
12.6. Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
12.7.1. China Central Nervous System Drugs Market
12.7.1.1. China Central Nervous System Drugs Market Overview
12.7.1.2. China Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.1.3. China Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2. Australia Central Nervous System Drugs Market
12.7.2.1. Australia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2.2. Australia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.3. Hong Kong Central Nervous System Drugs Market
12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4. India Central Nervous System Drugs Market
12.7.4.1. India Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4.2. India Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5. Indonesia Central Nervous System Drugs Market
12.7.5.1. Indonesia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5.2. Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6. Japan Central Nervous System Drugs Market
12.7.6.1. Japan Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6.2. Japan Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.7. Malaysia Central Nervous System Drugs Market
12.7.7.1. Malaysia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.8. New Zealand Central Nervous System Drugs Market
12.7.8.1. New Zealand Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.9. Philippines Central Nervous System Drugs Market
12.7.9.1. Philippines Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.10. Singapore Central Nervous System Drugs Market
12.7.10.1. Singapore Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11. South Korea Central Nervous System Drugs Market
12.7.11.1. South Korea Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11.2. South Korea Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.12. Thailand Central Nervous System Drugs Market
12.7.12.1. Thailand Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.13. Vietnam Central Nervous System Drugs Market
12.7.13.1. Vietnam Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Central Nervous System Drugs Market
13.1. Western Europe Central Nervous System Drugs Market Overview
13.2. Western Europe, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
13.3. Western Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
13.4. Western Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
13.5. Western Europe, Central Nervous System Drugs Market Metrics
13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Western Europe Countries
13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Western Europe Countries
13.6. Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7. Western Europe Central Nervous System Drugs Market: Country Analysis
13.7.1. Austria Central Nervous System Drugs Market
13.7.1.1. Austria Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2. Belgium Central Nervous System Drugs Market
13.7.2.1. Belgium Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.3. Denmark Central Nervous System Drugs Market
13.7.3.1. Denmark Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4. Finland Central Nervous System Drugs Market
13.7.4.1. Finland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5. France Central Nervous System Drugs Market
13.7.5.1. France Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5.2. France Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6. Germany Central Nervous System Drugs Market
13.7.6.1. Germany Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6.2. Germany Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.7. Ireland Central Nervous System Drugs Market
13.7.7.1. Ireland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.8. Italy Central Nervous System Drugs Market
13.7.8.1. Italy Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.9. Netherlands Central Nervous System Drugs Market
13.7.9.1. Netherlands Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.10. Norway Central Nervous System Drugs Market
13.7.10.1. Norway Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11. Portugal Central Nervous System Drugs Market
13.7.11.1. Portugal Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.12. Spain Central Nervous System Drugs Market
13.7.12.1. Spain Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.13. Sweden Central Nervous System Drugs Market
13.7.13.1. Sweden Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.14. Switzerland Central Nervous System Drugs Market
13.7.14.1. Switzerland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15. UK Central Nervous System Drugs Market
13.7.15.1. UK Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15.2. UK Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Central Nervous System Drugs Market
14.1. Eastern Europe Central Nervous System Drugs Market Overview
14.2. Eastern Europe, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
14.3. Eastern Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
14.4. Eastern Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Eastern Europe, Central Nervous System Drugs Market Metrics
14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Eastern Europe Countries
14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Eastern Europe Countries
14.6. Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis
14.7.1. Czech Republic Central Nervous System Drugs Market,
14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.2. Poland Central Nervous System Drugs Market
14.7.2.1. Poland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.3. Romania Central Nervous System Drugs Market
14.7.3.1. Romania Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4. Russia Central Nervous System Drugs Market
14.7.4.1. Russia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4.2. Russia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Central Nervous System Drugs Market
15.1. North America Central Nervous System Drugs Market Overview
15.2. North America, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
15.3. North America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
15.4. North America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. North America, Central Nervous System Drugs Market Metrics
15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, North America Countries
15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, North America Countries
15.6. North America Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7. North America Central Nervous System Drugs Market: Country Analysis
15.7.1. Canada Central Nervous System Drugs Market
15.7.1.1. Canada Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.2. Mexico Central Nervous System Drugs Market
15.7.2.1. Mexico Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3. USA Central Nervous System Drugs Market
15.7.3.1. USA Central Nervous System Drugs Market Overview
15.7.3.2. USA Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3.3. USA Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Central Nervous System Drugs Market
16.1. South America Central Nervous System Drugs Market Overview
16.2. South America, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
16.3. South America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
16.4. South America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. South America, Central Nervous System Drugs Market Metrics
16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, South America Countries
16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, South America Countries
16.6. South America Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7. South America Central Nervous System Drugs Market: Country Analysis
16.7.1. Argentina Central Nervous System Drugs Market
16.7.1.1. Argentina Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2. Brazil Central Nervous System Drugs Market
16.7.1.1. Brazil Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2.2. Brazil Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3. Chile Central Nervous System Drugs Market
16.7.3.1. Chile Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.4. Colombia Central Nervous System Drugs Market
16.7.4.1. Colombia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.5. Peru Central Nervous System Drugs Market
16.7.5.1. Peru Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.6. Venezuela Central Nervous System Drugs Market
16.7.6.1. Venezuela Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17. Middle East Central Nervous System Drugs Market
17.1. Middle East Central Nervous System Drugs Market Overview
17.2. Middle East, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
17.3. Middle East, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
17.4. Middle East, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. Middle East, Central Nervous System Drugs Market Metrics
17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Middle East Countries
17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Middle East Countries
17.6. Middle East Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7. Middle East Central Nervous System Drugs Market: Country Analysis
17.7.1. Saudi Arabia Central Nervous System Drugs Market
17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2. Israel Central Nervous System Drugs Market
17.7.2.1. Israel Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.3. Turkey Central Nervous System Drugs Market
17.7.3.1. Turkey Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.4. UAE Central Nervous System Drugs Market
17.7.4.1. UAE Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Central Nervous System Drugs Market
18.1. Africa Central Nervous System Drugs Market Overview
18.2. Africa, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
18.3. Africa, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
18.4. Africa, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. Africa, Central Nervous System Drugs Market Metrics
18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Africa Countries
18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Africa Countries
18.6. Africa Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7. Africa Central Nervous System Drugs Market: Country Analysis
18.7.1. Egypt Central Nervous System Drugs Market
18.7.1.1. Egypt Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.2. Nigeria Central Nervous System Drugs Market
18.7.2.1. Nigeria Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.3. South Africa Central Nervous System Drugs Market
18.7.3.1. South Africa Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Central Nervous System Drugs Market Competitive Landscape
19.1. Competitive Market Overview
19.2. Market Shares
19.3. Company Profiles
19.3.1. Biogen Inc
19.3.1.1. Company Overview
19.3.1.2. Products And Services
19.3.1.3. Strategy
19.3.1.4. Financial Performance
19.3.2. F. Hoffmann-La Roche Ltd
19.3.2.1. Company Overview
19.3.2.2. Products And Services
19.3.2.3. Strategy
19.3.2.4. Financial Performance
19.3.3. Johnson & Johnson
19.3.3.1. Company Overview
19.3.3.2. Products And Services
19.3.3.3. Strategy
19.3.3.4. Financial Performance
19.3.4. Pfizer Inc
19.3.4.1. Company Overview
19.3.4.2. Products And Services
19.3.4.3. Strategy
19.3.4.4. Financial Performance
19.3.5. Novartis AG
19.3.5.1. Company Overview
19.3.5.2. Products And Services
19.3.5.3. Strategy
19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
21. Market Background: Pharmaceutical Drugs Market
21.1. Pharmaceutical Drugs Market Characteristics
21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
22. Recommendations
22.1. Global Central Nervous System Drugs Market In 2023- Growth Countries
22.2. Global Central Nervous System Drugs Market In 2023- Growth Segments
22.3. Global Central Nervous System Drugs Market In 2023- Growth Strategies
23. Appendix
23.1. NAICS Definitions Of Industry Covered In This Report
23.2. Abbreviations
23.3. Currencies
23.4. Research Inquiries
23.5. The Business Research Company
24. Copyright And Disclaimer